Because of a lapse in government funding, the information on this website may not be up to date transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at


  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

This page contains brief information about palbociclib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA Approval for Palbociclib (2017)

FDA Approval for Palbociclib (2016)

FDA Approval for Palbociclib (2015)

Use in Cancer

Palbociclib is approved to be used with other drugs to treat:

Palbociclib is also being studied in the treatment of other types of cancer.

More About Palbociclib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Palbociclib - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

FDA Approves Ribociclib, Expands Palbociclib Approval for Metastatic Breast Cancer

Palbociclib Improves Survival in Women with Hormone Receptor-Positive Metastatic Breast Cancer

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Palbociclib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: February 10, 2015
  • Updated: July 13, 2017